IOBT Stock Analysis: Buy, Sell, or Hold?
IOBT - IO Biotech, Inc. Common Stock
$0.05
0.02 (48.61%)
▲
5d:
-75.13%
30d:
-85.27%
90d:
-92.85%
WAIT
LOW Confidence
Analysis Updated: Apr 6, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When IOBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IOBT is down 75.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IOBT is down 75.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IOBT is currently trading at $0.05, which is considered fair based on recent price action.
Technical Outlook: Technically, IOBT is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.22. The stock is showing strong short-term momentum, up 48.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.18 (+4441.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IOBT is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.22. The stock is showing strong short-term momentum, up 48.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.18 (+4441.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+48.6%)
- BULLISH: Trading 4441.7% below Wall St target ($2.18)
- WARNING: Recommendation downgraded due to -75.1% 5-day decline - wait for stabilization
Support & Resistance Levels
Support Level
$0.03
Resistance Level
$0.22
Current Trend
Strong Downtrend
Technical data as of
Apr 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$2.18
(+4441.7%)
Share & Embed Analysis
Last updated: May 18, 2026 9:43 AM ET
Data refreshes hourly during market hours. Next update: 10:43 AM
Data refreshes hourly during market hours. Next update: 10:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
